Amarin Corp Plcuk (AMRN) Gains from Sales and Divestitures (2013 - 2025)

Amarin Corp Plcuk (AMRN) reported Gains from Sales and Divestitures of $8.5 million for Q4 2025, up 121.78% year-over-year from $3.9 million in Q4 2024, and up 121.78% quarter-over-quarter from $3.9 million in Q4 2024.

Amarin Corp Plcuk (AMRN) Gains from Sales and Divestitures (2013 - 2025) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 12 years of Gains from Sales and Divestitures data on file, last reported at $8.5 million in Q4 2025.

  • Gains from Sales and Divestitures for Q4 2025 came in at $8.5 million, up 121.78% year-over-year; the trailing twelve-month figure through Dec 2025 was $8.5 million (up 121.78% YoY), and the FY2025 annual result was $8.5 million, up 121.78% from the prior year.
  • Gains from Sales and Divestitures grew to $8.5 million in Q4 2025 per AMRN's latest filing, from $3.9 million in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $8.5 million in Q4 2025 and troughed at $1.9 million in Q4 2022.
  • A 5-year average of $4.5 million and a median of $4.1 million in 2021 frame the typical range for Gains from Sales and Divestitures.
  • The sharpest annual moves came in 2022 and 2025: Gains from Sales and Divestitures sank 52.18% in 2022, then jumped 121.78% in 2025.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $4.1 million in 2021, then slumped by 52.18% to $1.9 million in 2022, then soared by 119.02% to $4.2 million in 2023, then slipped by 9.34% to $3.9 million in 2024, then soared by 121.78% to $8.5 million in 2025.
  • Business Quant data shows AMRN's Gains from Sales and Divestitures at $8.5 million in Q4 2025, $3.9 million in Q4 2024, and $4.2 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 8.54 Mn
Dec 31, 2025 8.54 Mn
Dec 31, 2024 3.85 Mn
Dec 31, 2024 3.85 Mn
Dec 31, 2023 4.25 Mn
Dec 31, 2023 4.25 Mn
Dec 31, 2022 1.94 Mn
Dec 31, 2022 1.94 Mn
Dec 31, 2021 4.06 Mn
Dec 31, 2021 4.06 Mn
Dec 31, 2020 2.51 Mn
Dec 31, 2020 2.51 Mn
Dec 31, 2019 3.97 Mn
Dec 31, 2019 3.97 Mn
Dec 31, 2018 4.61 Mn
Dec 31, 2018 4.61 Mn
Dec 31, 2017 2.18 Mn
Dec 31, 2017 2.18 Mn
Dec 31, 2016 1.85 Mn
Dec 31, 2016 1.85 Mn